A pilot trial of human amniotic fluid for the treatment of COVID-19

OBJECTIVE: Vertical transmission from SARS CoV-2-infected women is uncommon and coronavirus has not been detected in amniotic fluid. Human amniotic products have a broad immune-mediating profile. Observing that many COVID-19 patients have a profound inflammatory response to the virus, we sought to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Selzman, Craig H., Tonna, Joseph E., Pierce, Jan, Vargas, Camila, Skidmore, Chloe, Lewis, Giavonni, Hatton, Nathan D., Phillips, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820830/
https://www.ncbi.nlm.nih.gov/pubmed/33482902
http://dx.doi.org/10.1186/s13104-021-05443-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820830/
https://www.ncbi.nlm.nih.gov/pubmed/33482902
http://dx.doi.org/10.1186/s13104-021-05443-9

Ejemplares similares